Insider Transactions

What Armata Pharmaceuticals, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

	3 months	12 months
Open-market buys	0	0
Sells	0	0
Total trades	0	3

Shares traded

	3 months	12 months
Acquired	0	0
Disposed	0	14,229,571
Net activity	+0	−14,229,571

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

All Buys Sells

Insider	Relation	Date	Transaction	Shares	Price	Value	Shares held
Birx Deborah	Chief Executive Officer	Jul 10	Withheld — tax / exercise cost · F	−14,041	$4.26	−$59.8K	198,417
Kyme Pierre	Chief Business Officer	Mar 14	Withheld — tax / exercise cost · F	−1,030	$10.54	−$10.9K	9,461
Birx Deborah	Chief Executive Officer	Mar 14	Withheld — tax / exercise cost · F	−4,919	$10.54	−$51.8K	212,458
Birx Deborah	Chief Executive Officer	Jul 10	Withheld — tax / exercise cost · F	−13,637	$2.27	−$31K	217,377
Kyme Pierre	Chief Business Officer	Mar 14	Withheld — tax / exercise cost · F	−1,027	$1.95	−$2K	10,491
Birx Deborah	Chief Executive Officer	Mar 14	Withheld — tax / exercise cost · F	−6,061	$1.95	−$11.8K	231,014
Birx Deborah	Chief Executive Officer	Jul 10	Withheld — tax / exercise cost · F	−22,925	$2.68	−$61.4K	237,075
Rychlik Richard	Corporate Controller and PFO	Mar 14	Grant / award · A	+10,000	—	—	10,000
Birx Deborah	Chief Executive Officer	Mar 14	Grant / award · A	+60,000	—	—	260,000
Birx Deborah	Chief Executive Officer	Dec 21	Grant / award · A	+200,000	—	—	200,000
Theravance Inc	Director	Mar 31	Open-market buy · P	+5,385,208	$5.00	+$26.9M	16,365,969
Theravance Inc	Director	Feb 09	Open-market buy · P	+3,614,792	$5.00	+$18.1M	10,980,761
Theravance Inc	Director	Oct 29	Open-market buy · P	+1,212,122	$3.30	+$4M	7,365,969
Theravance Inc	Director	Mar 17	Open-market buy · P	+4,285,935	$3.25	+$13.9M	6,153,847
Theravance Inc	Director	Jan 26	Open-market buy · P	+1,867,912	$3.25	+$6.07M	1,867,912
Theravance Inc	10% owner	Mar 27	Open-market buy · P	+7,717,661	$2.87	+$22.1M	8,710,800
Perry Michael S	Director	Mar 22	Open-market buy · P	+181,820	$1.10	+$200K	411,105
Cook Jeremy Curnock	Director	Mar 22	Open-market buy · P	+181,820	$1.10	+$200K	411,105
Grint Paul C	Chief Executive Officer	Dec 08	Grant / award · A	+599	$0.62	+$371	599
Perry Michael S	Director	Sep 19	Open-market buy · P	+105,015	—	—	229,285

Page 1 of 10 · showing the 20 most recent Sign up free to view all 200 transactions and filter by insider →

Comments